63. M gge A, Daniel WG, Frank G, et al. Echocardiography in infective endo- carditis: reassessment of prognostic implications of vegetation size deter- mined by the transthoracic and the transesophageal approach. J Am Coll Cardiol. 1989;14:631 8. 64. Rohmann S, Erbel R, Darius H, et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr. 1991;4:465 74. 65. Habib G. Embolic risk in subacute bacterial endocarditis: determinants and role of transesophageal echocardiography. Curr Infect Dis Rep. 2005;7:264 71. 66. Truninger K, Attenhofer Jost CH, Seifert B, et al. Long term follow up of prosthetic valve endocarditis: what characteristics identify patients who were treated successfully with antibiotics alone? Heart. 1999;82:714 20. 67. Fosbol EL, Park LP, Chu VH, et al. The association between vegetation size and surgical treatment on 6-month mortality in left-sided infective endocarditis. Eur Heart J. 2019;40:2243 51. 68. Suzuki M, Takanashi S, Ohshima Y, et al. Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes. Int J Car- diol. 2017;227:222 4. 69. Garc a-Borbolla Fern ndez R, Sancho Jald n M, Calle P rez G, et al. Per- cutaneous treatment of mitral valve periprosthetic leakage. An alternative to high-risk surgery? Rev Esp Cardiol. 2009;62:438 41. 70. Nietlispach F, Johnson M, Moss RR, et al. Transcatheter closure of paraval- vular defects using a purpose-specific occluder. JACC Cardiovasc Interv. 2010;3:759 65. 71. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocar- ditis on pacemaker leads: clinical presentation and management. Circula- tion. 1997;95:2098 107. 72. Baddour LM, Cha Y-M, Wilson WR. Clinical practice. Infections of cardio- vascular implantable electronic devices. N Engl J Med. 2012;367:842 9. 73. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient character- istics and the effect on mortality in endocarditis. 